These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nail, skin, and scleral pigmentation induced by minocycline. Angeloni VL; Salasche SJ; Ortiz R Cutis; 1987 Sep; 40(3):229-33. PubMed ID: 3652731 [TBL] [Abstract][Full Text] [Related]
3. Pigmentation and retinopathy due to chloroquine. Stewart TW; Miles DW; Earnshaw ER Acta Derm Venereol; 1968; 48(1):47-52. PubMed ID: 4174103 [No Abstract] [Full Text] [Related]
7. [Ocular pigmentation and phenothiazine derivatives]. Calluaud JL; Di Battista JC; Douenne JL; Lagoutte F Bull Soc Ophtalmol Fr; 1977; 77(7-8):661-4. PubMed ID: 26474 [No Abstract] [Full Text] [Related]
8. Structural and ultrastructural changes to the sclera in a mammalian model of high myopia. McBrien NA; Cornell LM; Gentle A Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2179-87. PubMed ID: 11527928 [TBL] [Abstract][Full Text] [Related]
9. [Lesions of the macula caused by corticosteroids]. Pau H Ber Zusammenkunft Dtsch Ophthalmol Ges; 1978; (75):598. PubMed ID: 743166 [No Abstract] [Full Text] [Related]
13. [Eye pigmentation disorders in patients treated with phenothiazines]. Sizaret P; Quéré M; Degiovanni E; Degiovanni A Encephale; 1968; 57(6):515-24. PubMed ID: 5730657 [No Abstract] [Full Text] [Related]
14. [Ophthalmologic manifestations, with or without associated skin disorders, during prolonged treatment with chlorpromazine]. Baron JB; Morel P; Rivoallan Y; Soulairac A Agressologie; 1968; 9(2):293-304. PubMed ID: 5675496 [No Abstract] [Full Text] [Related]
15. [Ultrastructural study of ocular pigmentation due to phenothiazines]. Sizaret P; Rossazza C; Brassart B Rev Otoneuroophtalmol; 1975; 47(4):247-51. PubMed ID: 1215727 [No Abstract] [Full Text] [Related]
16. [Synthetic antimalarials and skin]. Ribrioux A Ann Dermatol Venereol; 1990; 117(12):975-90. PubMed ID: 2150584 [No Abstract] [Full Text] [Related]
17. [The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments]. Lambert PA Encephale; 1971; 60(4):335-49. PubMed ID: 5004893 [No Abstract] [Full Text] [Related]
18. [Grey discoloration of the skin in a patient on a long-term bismuth therapy]. Plísek V; Krátký J; Habanec B Vnitr Lek; 1970 Nov; 16(11):1085-90. PubMed ID: 5488287 [No Abstract] [Full Text] [Related]